Venturi Wealth Management’s Intellia Therapeutics NTLA Stock Holding History

Venturi Wealth Management’s Portfolio NTLA Stock Details NTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-43	Closed	-$1.75K	–	1399
2023 Q2	$1.75K	Sell	43 -15	-26%	-$608	﹤0.01%	942
2023 Q1	$2.16K	Buy	+58	New	+$2.27K	﹤0.01%	994
2021 Q4	–	Sell	-175	Closed	-$23K	–	355
2021 Q3	$23K	Buy	+175	New	+$26.5K	﹤0.01%	305

Other funds holding NTLA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Venturi Wealth Management's NTLA Position: Q3 2023 in Review

Venturi Wealth Management sold out of Intellia Therapeutics (NTLA) in Q3 2023, closing a stake of 43 shares — an estimated $1.75K sold.

Venturi Wealth Management first reported a position in NTLA in Q3 2021 and held it in 3 quarters. The position peaked at $23K in Q3 2021. 284 funds tracked by Wall St. Rank hold NTLA as of Q3 2023.

Venturi Wealth Management reported no remaining Intellia Therapeutics position as of Q3 2023 after selling out during the quarter.
Venturi Wealth Management sold 43 Intellia Therapeutics shares in Q3 2023, an estimated $1.75K.
Venturi Wealth Management first reported a position in Intellia Therapeutics in Q3 2021 and held it in 3 quarters.
Venturi Wealth Management's Intellia Therapeutics position peaked at $23K in Q3 2021.
284 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2023.

Based on Venturi Wealth Management's 13F filing for Q3 2023, filed 2 Nov 2023.